advanced search
Aptar Pharma

Ophthalmic Drug Delivery104

Issue No #104 Jan 2020  January 22nd, 2020


Download PDF


Inside the magazine

INTERVIEW WITH DR SRI MUDUMBA, SANTEN & DR GAUTAM SHETTY, CONGRUENCE
INTERVIEW
Dr Gautam N Shetty
Congruence Medical Solutions
INTERVIEW WITH DR SRI MUDUMBA, SANTEN & DR GAUTAM SHETTY, CONGRUENCE
In this interview, Dr Sri Mudumba, Santen, and Dr Gautam N Shetty, Congruence Medical Solutions, share insights from their experience of working together in developing the MDS for ophthalmic injections.
OPTIMISING OPHTHALMIC DRUG DELIVERY FOR THERAPEUTIC EFFECTIVENESS
EXPERT VIEW
Dr Barbara Morgan
OPTIMISING OPHTHALMIC DRUG DELIVERY FOR THERAPEUTIC EFFECTIVENESS
Barbara Morgan discusses how eye physiology impacts product formulation and choice of dosage form, and how advanced delivery technologies are providing new options for formulators seeking to improve the bioavailability or stability of their ophthalmic treatments.
DEVELOPING AN EFFICIENT OPHTHALMIC DEVICE COMBINATION PRODUCT
OCULAR
Zoe Davidson
Nemera
DEVELOPING AN EFFICIENT OPHTHALMIC DEVICE COMBINATION PRODUCT
Zoë Davidson looks at how understanding the patient journey can help develop an efficient ophthalmic device combination product.
DELIVERING ON THE GROWING NEED FOR TOPICAL PRESERVATIVE-FREE OPHTHALMIC TREATMENTS
OCULAR
Matthias Birkhoff
Aptar Pharma
DELIVERING ON THE GROWING NEED FOR TOPICAL PRESERVATIVE-FREE OPHTHALMIC TREATMENTS
Matthias Birkhoff provides an overview of existing ophthalmic delivery technologies and progress made within topically applied medications – and introduces a new market standard for testing microbial integrity in preservative-free formulation.
ADVANCED DRUG DELIVERY FOR DRY EYE TREATMENT
OCULAR
Rouven Kraus
Aero Pump
ADVANCED DRUG DELIVERY FOR DRY EYE TREATMENT
Rouven Kraus and Wilfried Woesthuis discuss Aero Pump and Medspray's new open-eye spray for the treatment of dry eyes.
Top

W3 Total Cache is currently running in Pro version Development mode.